MV is a lifesaving tool in therapeutic management, and is frequently performed in BI patients [
4,
5]. Despite being lifesaving, MV can exacerbate pulmonary and systemic inflammation, thus leading to ALI [
1]. Furthermore, it has been established that traditional MV with high tidal volumes (VT) is an independent risk factor for ALI in critically ill BI patients [
85]. Thus, MV could play a key role in the occurrence of acute respiratory failure in BI patients [
10].
The pathogenetic mechanisms include overstretching, repeated alveolar collapse, and re-expansion in each breath [
86]. Moreover, ventilator-associated lung injury could be triggered by the transformation of mechanical to biological stimuli in the lung [
87]. The result is a deleterious inflammatory cascade, which is associated with local tissue injury and potential spread to extrapulmonary organs and systems, a process that is often associated with multi-organ failure [
88].
On the other hand and as mentioned above, respiratory insufficiency is a common complication in critically ill BI patients. Despite the lack of evidence on the management of patients with both ABI and respiratory failure, it is clear that the ventilator strategy should be doubly protective for the lungs and the brain.
Hypoxia is common in neurocritical care patients, and it is well-established that partial arterial oxygen tension of 58 mmHg or SpO
2 below 90% in the first few hours after initiation of the BI is associated with a twofold risk of mortality [
89]. In addition, such a level of hypoxaemia could lead to decreased cerebral oxygen delivery, which ultimately could cause intracranial hypertension due to hypoxaemia-mediated vasodilation [
90].
Tidal volume
Although it is well-documented that protective MV—with low VT and positive end-expiratory pressure (PEEP)—decreases mortality in patients with ARDS, it is still unclear whether this ventilator strategy should be extended to all critically ill patients [
92], and it should be borne in mind that the protective ventilator strategy may lead to self-inflicted lung injury [
92] and hypercapnia [
85]. In particular in BI patients, modest increases in PaCO
2 are associated with cerebral vasodilation, resulting in intracranial hypertension, and higher cerebral blood volume [
10,
85]. On the other hand, BI patients are traditionally ventilated with high VT, on the basis of the observation that hypocapnia reduces ICP, and in order to maintain normal ICP [
10]. However, hyperventilation and the resulting hypocapnia can be detrimental for BI patients, especially during the first 24 h after the initiation of the event, when cerebral homeostasis is critically impaired [
93,
94]. As previously discussed, MV with high VT could induce further brain and lung injury (i.e., “second hit”) and extracranial organ failure [
7]. It is unfortunate that—due to the different pathophysiological mechanisms of ALI and safety issues—most important trials of lung protective ventilation exclude patients with ABI. Nevertheless, some studies have reported that ventilation with low VT achieves better neurophysiological protection and that this is associated with a lower incidence of ALI in critically ill neurological patients [
13,
95,
96], although it still debated whether the protective ventilation strategy should be extrapolated to the prehospital and emergency environment during the acute resuscitative phase (12–24 h) [
97]. Despite the lack of robust evidence, the recent recommendations of the European Society of ICM state that there is a consensus that the optimal range of PaCO
2 lies between 35–45 mmHg [
91]. Protective MV with VT of 6–8 ml/kg can help to avoid ALI [
4,
5,
10,
91].
PEEP
PEEP is part of the protective ventilation strategy to improve oxygenation and lung compliance. PEEP can not only prevent alveolar collapse, but also recruit collapsed alveoli. This then improves brain microcirculation, and finally reduces atelectasis [
1,
4,
5,
88,
98]. However, in BI patients, PEEP may also alter CBF, reduce cerebral venous return, and increase ICP [
85,
99,
100]. The mechanisms of ICP-elevation using PEEP are complex and involve many factors, including intracranial and intrathoracic compliance, systemic haemodynamic parameters, presence of hypovolemia and cerebral autoregulation [
1,
4,
5,
10]. Observational studies have demonstrated that high PEEP in patients with BI lead to reductions in cerebral perfusion pressure (CPP) and CBF- due to impaired haemodynamic parameters of the systemic circulation and especially mean arterial pressure (MAP) [
101,
102]. However, it has been suggested that the application of PEEP is only associated with increased ICP when PEEP causes alveolar hyperinflation. In contrast, when PEEP determines alveolar recruitment with reduction or no change in PaCO
2, there is no effect on cerebral perfusion or ICP [
7]. On the other hand, even if PEEP remains stable, it may cause an increase in intrathoracic pressure, and thus reduce MAP, venous return, and ICP [
103]. Maintenance of euvolemia, by using hypertonic solutions in particular, could probably minimize the effects of PEEP on CPP and MAP [
100].
Given the complex pathophysiological interactions between lungs and brain in critically ill patients with neurological injury, advanced monitoring that includes invasive ICP measurements, oxygen jugular saturation, and the partial oxygen pressure of brain tissue is recommended to optimize ventilation strategy and cerebral oxygen delivery in patients with ABI [
104].
Even though the various causes of BI appear to coalesce in common pathogenetic mechanisms [
22], specific recommendations and evidence should be considered for each specific subpopulation, in order to minimize the risk of pulmonary complications and cerebral dysfunction [
11]. The current consensus is that neurocritical patients without lung injury may benefit from a protective ventilation strategy for the lungs, using lower VT and moderate levels of PEEP. However, intensive multimodal monitoring is of major significance, in order to ensure cerebral and systemic haemodynamics.
Spontaneous breathing mechanical ventilation in acute brain injury
Patients with severe BI are often admitted in the ICUs for neuromonitoring and MV [
105]. Sedation and analgesia are frequently mandatory and have specific roles following ABI [
106]. They are used for several reasons: to control anxiety and motoric unrest, pain and agitation, avoid autonomic disability, control ICP, reduce brain metabolism, and optimize MV [
106,
107]. In the general adult and paediatric ICU patients, light rather than deep sedation is recommended, for mechanically ventilated patients, in order to shorten the duration of MV and length of hospital stay [
108,
109]. Unfortunately, there is little evidence for neurocritical care patients, because BI patients are often excluded in these studies [
110,
111]. On the other hand, brief cessation of sedation for daily wake-up tests may be beneficial to critically ill BI patients, by allowing clinical neuromonitoring, the detection of early warning neurological signs and neuroanatomical localization of pathology, and by helping to guide appropriate therapy [
112,
113]. Daily neurological assessments may be able to reduce the duration of MV and the need for tracheostomy [
114]. However, withdrawal of sedation may result in significant activation of the sympathetic autonomic system, with deterioration in cerebral haemodynamics [
113], so that the benefits of daily neurological assessments must be weighed against the associated risks.
In contrast to non-neurocritical care patients, BI patients usually do not have the primary respiratory indication for ventilator support [
115,
116]. Moreover, BI patients are subject to prolonged MV and delayed extubation [
87,
117], despite the fact that they are often able to breathe spontaneously [
115,
116].
However, while interest in the use of partially supported breathing modes is increasing [
118,
119], the role of spontaneous breathing [
120] ventilation in patients with ABI is less well-established [
121]. Spontaneous respiratory effort has been shown to be beneficial by improving gas exchange and oxygenation, haemodynamics, and non-pulmonary organ function [
10,
106,
122‐
124]. Moreover, SB is associated with reduced sedation [
125], thus facilitating daily neurological assessment. In addition, SB seems to prevent diaphragmatic dysfunction by allowing diaphragmatic muscle contractions [
126], improving ventilation-perfusion matching, recruiting the lungs [
123] and reducing dead space [
127]. Thus, many neurocritical care physicians allow light sedation, if this is tolerated by the patient.
On the other hand, there is accumulating evidence that SB may cause or even worsen ALI [
123]. SB contributes to the transpulmonary pressure, thus resulting in a proportional increase in VT [
123]. Moreover, SB exertion may also increase transvascular pulmonary pressure, thus leading to pulmonary oedema and VILI [
123,
128]. Furthermore, the “pendelluft” phenomenon during SB-MV may contribute to ALI by overstretching the dependent lung areas [
122]. Finally, asynchrony between patient and ventilator can exacerbate ALI and is associated with prolonged MV and increased mortality [
14,
129]. “Double triggering” is one of the most common forms of asynchrony between the patient’s exertions and the ventilator [
129,
130] and may result in large VTs with injurious effects [
129,
131].
In summary, even though there are no clinical studies in patients with ABI, experimental data, preliminary results of a clinical study and observational findings in patients with ALI/ARDS suggest that SB-ventilation can be used without undue harm [
122]. As the use of VT as a surrogate marker for lung distension and inspiratory exertion has limitations, there is an urgent need to find new methods to establish the safety of SB ventilation [
132]. Reliable assessment of respiratory drive and inspiratory effort is essential to estimate the balance between beneficial and deleterious consequences of SB during the MV of BI patients [
122,
128,
132].